Clinical trial
Sufentanil Sublingual Tablet System For Management Of Postoperative Pain In Enhanced Recovery After Surgery Pathway For Total Knee Arthroplasty: A Randomized Controlled Study
NCT04448457 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Tivoli as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sufentanil Sublingual Tablet System For Management Of Postoperative Pain In Enhanced Recovery After Surgery Pathway For Total Knee Arthroplasty: A Randomized Controlled Study
- Lead sponsor
- Centre Hospitalier Universitaire de Tivoli
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 1, 2017
- Completion date
- July 31, 2018
- Enrollment
- 72 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.